Rafael Montejano Milner

Rafael Montejano Milner

Ophthalmology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Closed access
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
ALA. López-Gaona
A. López-Gaona
PFP. Fernández-Pérez
P. Fernández-Pérez
MSM. Sánchez-Orgaz
M. Sánchez-Orgaz
RRR. Romero-Martín
R. Romero-Martín
AAA. Arbizu-Duralde
A. Arbizu-Duralde

Verified
Journal Article
Open access
PDF file
ABAna Boto-de-los-Bueis
Ana Boto-de-los-Bueis
MLMiguel de la Fuente López
Miguel de la Fuente López
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
AZAlmudena del Hierro Zarzuelo
Almudena del Hierro Zarzuelo
Elena VecinoElena Vecino
Elena Vecino
Arantxa AceraArantxa Acera
Arantxa Acera
Ocular diseases have a strong impact on individuals, the effects of which extend from milder visual impairment to blindness. Due to this and to their prevalence, these conditions constitute important health, social and economic challenges. Thus, improvements in their early detection and diagnosis will help dampen the impact of these conditions, both on patients and on healthcare systems alike. In this sense, identifying tear biomarkers could establish better non-invasive approaches to diagnose these diseases and to monitor responses to therapy. With this in mind, we developed a solid phase capture assay, based on antibody microarrays, to quantify S100A6, MMP-9 and CST4 in human tear samples, and we used these arrays to study tear samples from healthy controls and patients with Sjögren’s Syndrome, at times concomitant with rheumatoid arthritis. Our results point out that the detection of S100A6 in tear samples seems to be positively correlated to rheumatoid arthritis, consistent with the systemic nature of this autoinflammatory pathology. Thus, we provide evidence that antibody microarrays may potentially help diagnose certain pathologies, possibly paving the way for significant improvements in the future care of these patients.

3 December 2021 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
CAC. Arruabarrena
C. Arruabarrena
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
FAF. de Aragón
F. de Aragón
GAG. Allendes
G. Allendes
MTM.A. Teus
M.A. Teus

22 June 2021 in Orbit
Verified
Journal Article
Closed access
PFPedro Fernández-Pérez
Pedro Fernández-Pérez
RRRicardo Romero-Martín
Ricardo Romero-Martín
BGBárbara González-Ferrer
Bárbara González-Ferrer
MSMargarita Sánchez-Orgaz
Margarita Sánchez-Orgaz
ÁAÁlvaro Arbizu-Duralde
Álvaro Arbizu-Duralde
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
Purpose: Many surgical approaches have been described for achieving satisfactory functionality in patients with facial paralysis, to ensure the protection of the cornea and the highest degree of physiological blinking. Out of all those available, dynamic techniques are indicated when motion recovery and synchrony are the goals pursued. Orbicularis oculi transposition (OOT) allows a genuine restoration of blinking by means of contralateral reinnervation, with minimal insult for the donor site. Methods: We present the case of a 64-year-old man with unilateral facial paralysis. A physical examination revealed a lagophthalmos of more than 5 mm. A neurophysiological study showed a mild-to-moderate axonal injury of the left facial nerve. Contralateral OOT was indicated as the first therapy option since it can restore involuntary blinking. The orbicularis muscle flap was not divided into branches, as described previously by other authors; the whole flap was transposed to the paralysed upper eyelid to achieve the highest level of potential reinnervation. Results: Lagophthalmos was fully corrected after the surgery. The patient reported subjective improvement of symptoms, less frequent instillation of artificial tear drops and, especially, synchronous blinking with significant improvement in involuntarity. These improvements were maintained after 1 year of follow-up. Postoperative electromyographic studies confirmed the improvement in neural function. Conclusions: OOT can be a safe and effective option for the treatment of patients with peripheral facial paralysis, as it achieves a good restoration of blinking function with minimal morbidity in the healthy donor eye.

1 February 2022 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
ALA. López-Gaona
A. López-Gaona
PFP. Fernández-Pérez
P. Fernández-Pérez
MSM. Sánchez-Orgaz
M. Sánchez-Orgaz
RRR. Romero-Martín
R. Romero-Martín
AAA. Arbizu-Duralde
A. Arbizu-Duralde

4 December 2024 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Closed access
Rafael Montejano MilnerRafael Montejano Milner
Rafael Montejano Milner
MSM. Sánchez-Orgaz
M. Sánchez-Orgaz
RRR. Romero-Martín
R. Romero-Martín
JDJ.V. Dabad-Moreno
J.V. Dabad-Moreno
IMI. Mogollón-Giralt
I. Mogollón-Giralt
ÁAÁ. Arbizu-Duralde
Á. Arbizu-Duralde